The thyrotropin-releasing hormone test may predict recurrence of clinical depression within ten years after discharge

Neuroendocrinology Letters

Volumn 34, Issue 5, 2013, Pages 409-417

  Tsuru, Jusen ^a   Ishitobi, Yoshinobu ^a   Ninomiya, Taiga ^a   Kanehisa, Masayuki ^a   Imanaga, Junko ^a   Inoue, Ayako ^a   Okamoto, Shizuko ^a   Maruyama, Yoshihiro ^a   Higuma, Haruka ^a   Tanaka, Yoshihiro ^a   Hanada, Hiroaki ^a   Isogawa, Koichi ^a   Akiyoshi, Jotaro ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Biological marker; Depression; DEX CRH test; Prediction of outcome; TRH test

Indexed keywords

AMOXAPINE; CLOMIPRAMINE; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; DOSULEPIN; FLUVOXAMINE; IMIPRAMINE; MIANSERIN; NORTRIPTYLINE; PROTIRELIN; SULPIRIDE; THYROTROPIN; TRAZODONE;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATIONAL STUDY; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ENDOCRINE FUNCTION TEST; FEMALE; HOSPITAL DISCHARGE; HUMAN; INTERMETHOD COMPARISON; MAJOR DEPRESSION; MALE; OUTPATIENT; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; PROTIRELIN TEST; RECURRENCE RISK; REMISSION; THYROTROPIN BLOOD LEVEL;

EID: 84884918163     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. American Psychiatric Association (2000) Diagnostic and Statistical manual of mental disorders (4th ed., text revision). Washington DC: American Psychiatric Association.
2. Amsterdam JD, Fava M, Maislin G, Rosenbaum J, Hornig-Rohan M (1996). TRH stimulation test as a predictor of acute and long-term antidepressant response in major depression. J Affect Disord. 38: 165-172. (Pubitemid 26191501)
3. Aronson R, Offman HJ, Joffe RT, Naylor CD (1996). Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis. Arch Gen Psychiatry. 53: 842-848. (Pubitemid 26303624)
4. Banki CM, Bissette G, Arato M, Nemeroff CB (1988). Elevation of immunoreactive CSF TRH in depressed patients. Am J Psychiatry. 145: 1526-1531. (Pubitemid 19009699)
5. Callahan AM, Frye MA, Marangell LB, George MS, Ketter TA, L'Herrou T et al. (1997). Comparative antidepressant effects of intravenous and intrathecal thyrotropin-releasing hormone: confounding effects of tolerance and implications for therapeutics. Biol Psychiatry. 41: 264-272. (Pubitemid 27098827)
6. Carpenter L, Ross NS, Tyrka AR, Anderson GM, Kelly M, Price LH (2009). Dex/CRH test Cortisol response in outpatients with major depression and matched healthy controls. Psychoneuroendocrinology. 34: 1208-1213.
7. Cooper-Kazaz R, Apter JT, Cohen R, Karagichev L, Muhammed-Moussa S, Grupper D et al. (2007). Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry. 64: 679-688. (Pubitemid 46878668)
8. Coppen A, Montgomery S, Peet M, Bailey J, Marks V, Woods P (1974). Thyrotropine-releasing hormone in the treatment of depression. Lancet. 2: 433-444.
9. Correa H, Duval F, Claude MM, Bailey P, Tremeau F, Diep TS et al. (2001). Noradrenergic dysfunction and antidepressant treatment response. Eur Neuropsychopharmacol. 11: 163-168. (Pubitemid 32366478)
10. Crown WH, Finkelstein S, Berndt ER, Ling D, Poret AW, Rush et al. (2002). The impact of treatment-resistant depression on health care utilization and costs. J. Clin Psychiatry. 63: 963-971. (Pubitemid 35388053)
11. Duval F, Macher JP, Mokrani MC (1990). Difference between evening and morning thyrotropin responses to protirelin in major depressive episode. Arch Gen Psychiatry. 147: 443-448. (Pubitemid 20161263)
12. Duval F, Mokrani MC, Crocq MA, Jautz M, Bailey P, Diep TS et al. (1996). Effect of antidepressant medication on morning and evening thyroid function tests during a major depressive episode. Arch Gen Psychiatry. 53: 833-840. (Pubitemid 26303623)
13. Erhardt A, Ising M, Unschuld PG, Kern N, Lucae S, Putz B et al. (2006). Regulation of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder. Neuropsychopharmacology. 31: 2515-2522. (Pubitemid 44607071)
14. Extein I, Pottash AL, Gold MS, Silver JM (1982). Thyroid-stimulating hormone response to thyrotropin-releasing hormone in unipolar depression before and after clinical improvement. Psychiatry Res. 6: 161-169. (Pubitemid 12119838)
15. Extein I, Pottash AL, Gold MS (1981). Relationship of Thyrotropin-releasing hormone test and dexamethasone suppression test abnormalities in unipolar depression. Psychiatry Res. 4: 49-53. (Pubitemid 11131776)
16. Gregoire F, Brauman H, De Buck R, Corvilain J (1977). Hormone release in depressed patients before and after recovery. Psychoneuroendocrinology. 2: 303-312. (Pubitemid 8158446)
17. Hamilton M (1967). Development of a rating scale for primary depressive illness. B J Soc Clin Psychol. 6: 278-296.
18. Hatterer JA, Herbert J, Hidaka C, Roose SP, Gorman JM (1993). CSF transthyretin in patients with depression. Am J Psychiatry. 150: 813-815. (Pubitemid 23137692)
19. Hatzinger M, Hemmeter UM, Baumann K, Brand S, Holsboer-Trachsler E (2002). The combined DEX-CRH test in treatment course and long-term outcome of major depression. J Psychiatr Res. 36: 287-297. (Pubitemid 34764053)
20. Heuser I, Yassouridis A, Holsboer F (1994a). The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J Psychiatr Res. 28: 341-356. (Pubitemid 24370022)
21. Heuser IJ, Gotthardt U, Schweiger U, Schmider J, Lammers CH, Dettling M et al. (1994b). Age-associated changes of pituitary-adrenocortical hormone regulation in humans: importance of gender. Neurobiol Aging. 15: 227-231. (Pubitemid 24120831)
22. Heuser IJ, Schweiger U, Gotthardt U, Schmider J, Lammers CH, Dettling, M et al. (1996). Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. Am J Psychiatry. 153: 93-99. (Pubitemid 26026163)
23. Holsboer F (2000). The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. 23: 477-501.
24. Holsboer-Trachsler E, Stohler R, Hatzinger M (1991). Repeated administration of the combined dexamethasone human corticotrophin releasing hormone stimulation test during treatment of depression. Psychiatr Res. 38: 163-171.
25. Iosifescu DV, Nierenberg AA, Mischoulon D, Perlis RH, Papakostas GI, Ryan JL et al. (2005). Open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder. J Clin Psychiatry. 66: 1038-1042. (Pubitemid 41191797)
26. Iovino M, Steardo L, Monteleone P (1991). Impaired sensitivity of the hypothalamo-pituitary-thyroid axis to the suppressant effect of dexamethasone in elderly subjects. Psychopharmacology (Berl). 105: 481-484.
27. Ising M, Kunzel HE, Binder EB, Nickel T, Modell S, Holsboer F (2005). The combined dexamethasone/CRH test as a potential surrogate marker in depression. Prog Neuropsychopharmacol Biol Psychiatry. 29: 1085-1093. (Pubitemid 41080135)
28. Ising M, Horstmann S, Kloiber S, Lucae S, Binder EB, Kern N et al. 2007. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker? Biol Psychiatry. 62: 47-54. (Pubitemid 46898222)
29. Isogawa K, Nagayama H, Tsutsumi T, Kiyota A, Akiyoshi J, Hieda K (2005). Simultaneous use of thyrotropin-releasing hormone test and combined dexamethasone/corticotropine-releasing hormone test for severity evaluation and outcome prediction in patients with major depressive disorder. J Psychiatr Res. 39: 467-473. (Pubitemid 40909990)
30. Kastin AJ, Ehrensing RH, Schalch DS, Anderson MS (1972). Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone. Lancet. 2: 740-742.
31. Kirkegaard C, Faber J, Hummer L, Rogowski P (1979). Increased levels of TRH in cerebrospinal fluid from patients with endogenous depression. Psychoneuroendocrinology. 4: 227-235. (Pubitemid 10209953)
32. Kudielka BM, Schmidt-Reinwald AK, Hellhammer DH, Kirschbaum C (1999). Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment. Neuroendocrinology. 70: 422-430. (Pubitemid 30009031)
33. Kunugi H, Ida I, OwashiT, Kimura M, Inoue Y, Nakagawa S et al. (2006). Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study. Neuropsychopharmacology. 31: 212-220. (Pubitemid 43250958)
34. Kunugi H, Urushibara T, Nanko S (2004). Combined DEX/CRH test among Japanese patients with major depression. J Psychiatr Res. 38: 123-128. (Pubitemid 38134452)
35. Künzel HE, Binder EB, Nickel T, Ising TM, Fuchs B, Majer M (2003). Pharmacological and nonpharmacological factors influencing hypothalamic- pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test. Neuropsychopharmacology. 28: 2169-2178. (Pubitemid 37468184)
36. Lauer CJ, Schreiber W, Modell S, Holsboer F, Krieg JC (1998). The Munich vulnerability study on affective disorders: overview of the cross-sectional observations at index investigation. J Psychiatr Res. 32: 393-401. (Pubitemid 28491245)
37. Lesch KP, Müller U, Rupprecht R, Kruse K, Schulte HM (1989). Endocrine responses to growth hormone-releasing hormone, thyrotropin-releasing hormone and corticotropin-releasing hormone in depression. Acta Psychiatr Scand. 79: 597-602. (Pubitemid 19168606)
38. Loosen PT, Prange Jr AJ (1982). Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review. Am J Psychiatry. 139: 405-416. (Pubitemid 12141031)
39. Loosen PT (1985). The TRH-induced TSH response in psychiatric patients: a possible neuroendocrine marker. Psychoneuroendocrinology. 10: 237-260.
40. Marangell LB, George MS, Callahan AM, Ketter TA, Pazzaglia PJ, L'HerrouTA (1997). Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients. Arch Gen Psychiatry. 54: 214-222. (Pubitemid 27132050)
41. Oshima A, Yamashita S, Owashi T, Murata T, Tadokoro C, Miyaoka H (2000). The differential ACTH responses to combined dexamethasone/CRH administration in major depressive and dysthymic disorders. J Psychiatr Res. 34: 325-328.
42. Patil WV, Mujawar SA (2010). The relationship between cortisol and thyroid function tests in geriatric Patients with psychiatric disorder. Current Neurobiology. 1: 133-135.
43. Plotsky PM, Owens MJ, Nemeroff CB (1998). Psychoneuroendocrinology of depression: hypothalamic-pituitary-adrenal axis. Psychiatr Clin North Am. 21: 293-307. (Pubitemid 28311852)
44. Porter RJ, Gallagher P, Watson S, Young AH (2004). Corticosteroid- serotonin interactions in depression: a review of the human evidence. Psychopharmacology (Berlin). 173: 1-17. (Pubitemid 38607335)
45. Prange Jr AJ, Lara PP, Wilson IC, Alltop LB, Breese GR (1972). Effects of thyrotropin-releasing hormone in depression. Lancet. 2: 999-1002.
46. Rybakowski JK, Twardowska K (1999). The dexamethasone/corticotropin- releasing hormone test in depression in bipolar and unipolar affective illness. J Psychiatr Research. 33: 363-370. (Pubitemid 29392684)
47. Samuels MH, McDaniel PA (1997). Thyrotropin levels during hydrocortisone infusions that mimic fasting-induced cortisol elevations: a clinical research center study. J Clin Endocrinol Metab. 82: 3700-3704. (Pubitemid 27509358)
48. Strawn JR, Ekhator NN, D'Souza BB, Geracioti Jr TD (2004). Pituitary-thyroid state correlates with central dopaminergic and serotonergic activity in healthy humans. Neuropsychobiology. 49: 84-87. (Pubitemid 38253133)
49. Sullivan GM, Hatterer JA, Herbert J, Chen X, Roose SP, Attia E et al. (1999). Low levels of transthyretin in the CSF of depressed patients. Am J Psychiatry. 156: 710-715. (Pubitemid 29220068)
50. Targum SD (1984). Persistent neuroendocrine dysregulation in major depressive disorder: a marker for early recurrence. Biol Psychiatry. 19: 305-318.
51. Watson S, Gallagher P, Del-Estal D, Hearn A, Ferrier IN, Young AH (2002). Hypothalamic-pituitary-adrenal axis function in patients with chronic depression. Psychol Med. 32: 1021-1028.
52. Watson S, Gallagher P, Ritchie JC, Ferrier IN, Young AH (2004). Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br J Psychiatry.184: 496-502. (Pubitemid 38725709)
53. Zobel AW, Nickel T, Sonntag A, Uhr M, Holsboer F, Ising M (2001). Cortisol response in the combined dexamethasone/CRH test as predictor of recurrence in patients with remitted depression, a prospective study. J Psychiatr Res. 35: 83-94. (Pubitemid 32506751)